Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes
Abdel-Hamid, Nabil M¹; Nazmy, Maiiada H¹; Abdel-Ghany, Manal I²; Nazmy, Walaa H^2
1Minia University, Faculty of Pharmacy, El Cairo. Egipto; ²Minia University, Faculty of Medicine, El Cairo. Egipto
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 118-127]

Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis
Landeira, Graciela¹; Morise, Silvia²; Fassio, Eduardo¹; Ramonet, Margarita²; Alvarez, Estela³; Caglio, Patricia²; Longo, Cristina¹; Domínguez, Nora^1
1Hospital Nacional "Profesor Alejandro Posadas", Unidad de Hígado, El Palomar, Buenos Aires. Argentina; ²Hospital Nacional "Profesor Alejandro Posadas", Unidad Pediátrica de Hígado, El Palomar, Buenos Aires. Argentina; ³Hospital Nacional "Profesor Alejandro Posadas", Servicio de Patología, El Palomar, Buenos Aires. Argentina
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 100-106]

Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Medina Franco, Heriberto¹; Zamora Valdes, Daniel¹; Sánchez Ramón, Ariadne¹; Trejo Gómez, Gabriela^1
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Cirugía, México, Distrito Federal. México
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 128-129]

Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy
Mansukhani, Sasha¹; Shah, Ira^1
1B.J. Wadia Hospital for Children, Pediatric Tuberculosis Clinic, Parel, Mumbai. India
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 96-99]

Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?
Florentino, Gesira¹; Cotrim, Helma P¹; Florentino, Andre²; Padilha, Consuelo¹; Medeiros-Neto, Manoel²; Bragagnoli, Gerson³; Schwingel, Paulo^1
1Universidade Federal da Bahia, Hospital Universitario Prof. Edgard Santos, Salvador, Bahia. Brasil; ²Faculdade de Ciencias Medicas de Campina Grande, Campina Grande, Paraiba. Brasil; ³Universidade Federal de Campina Grande, Campina Grande, Paraiba. Brasil
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 147-149]

Intrafamilial seropositivity of hepatitis in patients with hepatitis B and C virus in hepatitis clinic in Hamadan, Iran
Ranjbar, Mitra¹; Golzardi, Zahra; Sedigh, Leila²; Nekoozadeh, Shahbaz^3
1Firoozgar Hospital, Department of Infectious Diseases, Teherán. Irán; ²Tehran University of Medical Sciences, Health System, Teherán. Irán; ³Tehran University of Medical Sciences, Department of Community Medicine, Teherán. Irán
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 32-36]

Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?
Aydin, Suleyman^1
1Firat University Hospital, Department of Medical Biochemistry and Clinical Biochemistry, Elazig. Turquía
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 145-146]

Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico
Mata Marín, José Antonio¹; Arroyo Anduiza, Carla Ileana¹; Calderón, Gloria María¹; Cázares Rodríguez, Sergio¹; Fuentes Allen, José Luis¹; Arias Flores, Rafael¹; Gaytán Martínez, Jesús^1
1Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, México, Distrito Federal. México
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 47-51]

Region 11 MELD Na exception prospective study
Fisher, Robert A¹; Douglas M. Heuman¹; Harper, Ann M²; Behnke, Martha K¹; Smith, Alastair D. ‡³; Russo, Mark W⁴; Zacks, Steven⁵; McGillicuddy, John W⁶; Eason, James⁷; Porayko, Michael K⁸; Northup, Patrick⁹; Marvin, Michael R¹⁰; Hundley, Johnathan¹¹; Nair, Satheesh^7
1Virginia Commonwealth University, Hume/Lee Transplant Center, Richmond, Virginia. Estados Unidos de América; ²United Network of Organ Sharing, Richmond, Virginia. Estados Unidos de América; ³Duke University Medical Center, Department of Medicine, Durham, Carolina del Norte. Estados Unidos de América; ⁴Carolinas Medical Center, Department of Medicine, Charlotte, Carolina del Norte. Estados Unidos de América; ⁵University of North Carolina, Department of Medicine, Chapel Hill, Carolina del Norte. Estados Unidos de América; ⁶Medical University of South Carolina, Department of Surgery, Charleston, Carolina del Sur. Estados Unidos de América; ⁷University of Tennessee Health Science Center, Methodist Transplant Institute, Memphis, Tennessee. Estados Unidos de América; ⁸Vanderbilt University Medical Center, Department of Medicine, Nashville, Tennessee. Estados Unidos de América; ⁹University of Virginia, Department of Medicine, Charlottesville, Virginia. Estados Unidos de América; ¹⁰University of Jewish Hospital, Department of Surgery, Louisville, Kentucky. Estados Unidos de América; ¹¹University of Kentucky, Department of Surgery, Lexington, Kentucky. Estados Unidos de América
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 62-67]

Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
Pessoa, Mario G¹; Cheinquer, Hugo²; Almeida, Paulo R.L³; Silva, Giovanni F⁴; Lima, Maria Patelli J.S⁵; Parana, Raymundo⁶; Lacerda, Marco A⁷; Parise, Edison R⁸; Pernambuco, Jose R.B⁹; Pedrosa, Suelene S¹⁰; Teixeira, Rosangela¹¹; Sette-Junior, Hoel¹²; Tatsch, Fernando
¹Universidade de Sao Paulo, Faculdade de Medicina, Sao Paulo. Brasil; ²Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul. Brasil; ³Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Rio Grande do Sul. Brasil; ⁴Universidade Estadual de Botucatu, Botucatu, Sao Paulo. Brasil; ⁵Pontificia Universidade Catolica de Campinas, Campinas, Sao Paulo. Brasil; ⁶Universidade Federal da Bahia, Salvador, Bahia. Brasil; ⁷Indiana University, Bloomington, Indiana. Estados Unidos de América; ⁸Universidade Federal de Sao Paulo, Sao Paulo. Brasil; ⁹Universidade Federal de Pernambuco, Recife, Pernambuco. Brasil; ¹⁰Santa Casa de Misericordia de Goiania, Goiania, Goias. Brasil; ¹¹Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais. Brasil; ¹²Hospital Alemao "Oswaldo Cruz", Sao Paulo. Brasil
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 52-61]

Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin
Maliken, Bryan D¹; Avrin, William F²; Nelson, James E¹; Mooney, Jody¹; Kumar, Sankaran²; Kowdley, Kris V^1
1Virginia Mason Medical Center, Digestive Disease Institute, Seattle, Washington. Estados Unidos de América; ²Insight Magnetics, San Diego, California. Estados Unidos de América
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 77-84]

Serum homocysteine levels in patients with nonalcoholic fatty liver diseas
Polyzos, Stergios A¹; Kountouras, Jannis¹; Patsiaoura, Kalliopi²; Katsiki, Evangelia²; Zafeiriadou, Efthimia³; Deretzi, Georgia⁴; Zavos, Christos¹; Gavalas, Emmanouel¹; Katsinelos, Panagiotis¹; Mane, Vasileia⁵; Slavakis, Aristidis^5
1Aristotle University of Thessaloniki, Second Medical Clinic, Thessaloniki, Macedonia. Grecia; ²Ippokration Hospital, Department of Pathology, Thessaloniki, Macedonia. Grecia; ³Ippokration Hospital, Department of Radiology, Thessaloniki, Macedonia. Grecia; ⁴Papageorgiou General Hospital, Department of Neurology, Thessaloniki, Macedonia. Grecia; ⁵Ippokration Hospital, Department of Biochemistry, Thessaloniki, Macedonia. Grecia
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 68-76]

Serum lipids and chronic hepatitis C genotype 4: interaction and significance
Khattab, Mahmoud A¹; Eslam, Mohammed¹; Aly, Mayada M¹; Shatat, Mohammed¹; Mousa, Yousef I¹; Abd-Aalhalim, Hesham¹; Aly, Hanan²; Shaker, Yehia^1
1Minia University, Department of Internal Medicine, Minia. Egipto; ²Beni-Suef University, Department of Internal Medicine, Beni Suef. Egipto
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 37-46]

Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis
Smyk, Daniel S¹; Rigopoulou, Eirini I²; Muratori, Luigi³; Burroughs, Andrew K⁴; Bogdanos, Dimitrios P^1
1King’s College Hospital, King’s College London School of Medicine, Londres. Reino Unido; ²University of Thessaly, Medical School, Larissa, Thessaly. Grecia; ³Policlinico Sant’Orsola Malpighi di Bologna, Dipartimento di Medicina Clinica, Bolonia, Emilia Romaña. Italia; ⁴Royal Free Hospital, The Sheila Sherlock Liver Centre, Londres. Reino Unido
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 7-14]

Unusual cause of common bile duct dilatation in asymptomatic elderly patient: right hepatic artery syndrome
Tas, Adnan; Koklu, Seyfettin^1
1Ankara Education and Research Hospital, Department of Gastroenterology, Ankara. Turquía
[Annals of hepatology, México, 2012 Vol. 11 Núm. 1 Ene-Feb, Pág. 150-151]

Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure
Kobashi Margáin, Ramón A¹; Gavilanes Espinar, Juan G¹; Gutiérrez Grobe, Ylse¹; Gutiérrez Jiménez, Angel A¹; Chávez Tapia, Norberto¹; Ponciano Rodríguez, Guadalupe²; Uribe, Misael¹; Méndez Sánchez, Nahum^1
1Fundación Clínica Médica Sur, Departamento de Investigación Biomédica, México, Distrito Federal. México; ²Universidad Nacional Autónoma de México, Facultad de Medicina, México, Distrito Federal. México
[Annals of hepatology, México, 2011 Vol. 10 , Pág. 70-76]

Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure
Pérez Hernández, José Luis¹; Higuera de la Tijera, Fátima¹; Serralde Zúñiga, Aurora Elizabeth¹; Abdo Francis, Juan Miguel^2
1Hospital General de México, Unidad de Hígado, México, Distrito Federal. México; ²Hospital General de México, Dirección Médica, México, Distrito Federal. México
[Annals of hepatology, México, 2011 Vol. 10 , Pág. 66-69]

Current indications for the use of albumin in the treatment of cirrhosis
Mattos, Angelo Alves de^1
1Irmandade da Santa Casa de Misericordia de Porto Alegre, Servico de Gastroenterologia e Hepatologia, Porto Alegre, Rio Grande do Sul. Brasil
[Annals of hepatology, México, 2011 Vol. 10 , Pág. 15-20]

Determination of ammonia concentrations in cirrhosis patients-still confusing after all these years?
Blanco Vela, Claudia Isabel¹; Bosques Padilla, Francisco Javier^1
1Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González, Monterrey, Nuevo León. México
[Annals of hepatology, México, 2011 Vol. 10 , Pág. 60-65]

Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy
Blanco Vela, Claudia Isabel¹; Poo Ramírez, Jorge Luis^2
1Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González, Monterrey, Nuevo León. México; ²Fundación Clínica Médica Sur, Departamento de Farmacología, México, Distrito Federal. México
[Annals of hepatology, México, 2011 Vol. 10 , Pág. P]